Efficacy and cost-effectiveness analysis of moxifloxacin hydrochloride and combination of ceftriaxone sodium with azithromycin in the treatment of moderate to severe community acquired pneumonia in elderly patients

Chinese Journal of New Drugs

Volumn 18, Issue 10, 2009, Pages 962-964

  Yang, Shu Gui ^a   Zhang, Shan Hong ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Azithromycin; Ceftriaxone sodium; Community acquired pneumonia; Cost effectiveness; Elderly; Moxifloxacin hydrochloride

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; MOXIFLOXACIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; PATIENT MONITORING; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT;

EID: 77954465054     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)